Registration, insurance, and medical application of biotechnological drugs in Russia

Existing approaches to the registration, insurance, and application of biotechnological drugs in Russia were analyzed using monoclonal antibody drugs and those produced using recombinant DNAtechnology as examples. Pharmacoeconomic aspects of using these drugs in the RF were described and compared wi...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutical chemistry journal 2013-02, Vol.46 (11), p.693-697
Main Authors: Ziganshina, L. E., Niyazov, R. R., Ziganshin, A. U.
Format: Article
Language:English
Subjects:
Drugs
Information
Medicine
Monoclonal antibodies
Organic Chemistry
Pharmacology/Toxicology
Pharmacy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Existing approaches to the registration, insurance, and application of biotechnological drugs in Russia were analyzed using monoclonal antibody drugs and those produced using recombinant DNAtechnology as examples. Pharmacoeconomic aspects of using these drugs in the RF were described and compared with WHO recommendations for their use.
ISSN:0091-150X
1573-9031
DOI:10.1007/s11094-013-0872-y